Neither prilocaine nor lidocaine is categorically better; each has a distinct safety and performance profile that makes it the stronger choice in specific clinical situations. Lidocaine remains the most widely used local anesthetic in the world and is the default in most dental and minor surgical settings. Prilocaine, developed a few years later, carries a wider margin of safety against serious systemic toxicity and causes fewer neurological side effects when injected into the spinal canal, but it comes with a unique risk of a blood disorder called methemoglobinemia that lidocaine rarely triggers. The real question is not which drug is universally superior but which one fits the procedure, the patient, and the dose.
How Both Drugs Numb You
Prilocaine and lidocaine belong to the same chemical family of amide-type local anesthetics. They work by slipping into voltage-gated sodium channels in nerve cells, blocking the electrical signals that carry pain sensations to the brain. Recent structural studies using cryo-electron microscopy have shown that these drugs enter the channel through small side openings, or fenestrations, that face the cell membrane.1Frontiers in Pharmacology / Europe PMC. Sodium Channels and Local Anesthetics-Old Friends With New Perspectives Because the core mechanism is the same, the two drugs feel similar from the patient’s perspective: you get an injection, the area goes numb within a few minutes, and sensation returns after a predictable window. The differences that matter clinically sit in their metabolism, their toxicity ceilings, and the side effects each one tends to produce.
Onset and Effectiveness in the Dental Chair
In dentistry, where both drugs see heavy use, head-to-head comparisons consistently show that prilocaine and lidocaine produce numbness at about the same speed. A trial comparing 2% lidocaine with 3% prilocaine for oral surgery found no statistically significant difference in how quickly patients reported numbness in the cheek tissue, the palate, or the tooth itself. The prilocaine group trended a few seconds faster on average, but the gap was too small to be meaningful statistically.2PubMed Central. 2% lidocaine versus 3% prilocaine for oral and maxillofacial surgery A separate study looking specifically at medically compromised patients reached the same conclusion: prilocaine showed slightly faster clinical onset and allowed teeth to be extracted a touch earlier, but again, the differences did not reach statistical significance.3PubMed Central. Is prilocaine safe and potent enough for use in the oral surgery of medically compromised patients
For most people sitting in a dental chair, the practical takeaway is simple: you are unlikely to notice any difference in how fast either drug kicks in or how well it controls pain during the procedure. The choice between them at the dentist usually comes down to other factors, like whether you have a heart condition that makes one vasoconstrictor pairing preferable over another, or whether the dose needed pushes you into the range where one drug’s toxicity profile matters more.
Injection Pain
One concern patients often have is whether one anesthetic stings more than the other going in. A double-blind study of over 300 dental injections compared prilocaine plain with lidocaine containing epinephrine and found no statistically significant difference in perceived injection pain. Roughly 87 percent of all injections, regardless of which drug was used, were rated by patients as causing no pain or only mild pain.4PubMed. Pain on injection of prilocaine plain vs. lidocaine with epinephrine. A prospective double-blind study Injection technique, needle gauge, and the speed of delivery tend to matter more for comfort than the drug itself.
Where Prilocaine Has a Real Safety Edge
The most important clinical difference between the two drugs is their systemic toxicity ceiling. When a local anesthetic accidentally enters the bloodstream in large amounts, it can cause seizures and, at higher levels, cardiac arrest. Prilocaine has a substantially higher threshold before these serious events occur. In a systematic review of adverse events during intravenous regional anesthesia, the lowest dose of local anesthetic associated with a seizure was about 1.4 mg per kilogram of body weight for lidocaine but 4 mg per kilogram for prilocaine. Cardiac arrests and deaths were reported with lidocaine and bupivacaine, but not with prilocaine.5PubMed. Adverse events associated with intravenous regional anesthesia (Bier block): a systematic review of complications Those same seizure-threshold figures have been confirmed in broader reviews of local anesthetic toxicity.6Dove Medical Press. Local anesthetic systemic toxicity: current perspectives
This wider safety margin is one of the main reasons prilocaine has long been a preferred agent for procedures where larger volumes of anesthetic are needed or where accidental intravascular injection is a concern. It does not mean lidocaine is dangerous at normal clinical doses; in routine dental work, the total dose administered is far below the seizure threshold for either drug. But in scenarios like regional nerve blocks or intravenous regional anesthesia, the difference in safety ceiling becomes relevant.
Methemoglobinemia, the Trade-Off
Prilocaine’s wider toxicity margin comes with a trade-off that lidocaine largely avoids. When the body breaks down prilocaine, one of the byproducts is a compound called o-toluidine, which can oxidize the iron in hemoglobin and convert it into methemoglobin, a form that cannot carry oxygen effectively. Lidocaine produces a different metabolite, 2,6-xylidine, which also has some capacity to generate methemoglobin, but laboratory studies show that prilocaine’s metabolic pathway generates significantly more of it. Experiments with human liver enzymes found that methemoglobin formation was higher when prilocaine and its metabolite o-toluidine were incubated with liver tissue compared with lidocaine and 2,6-xylidine.7Drug Metabolism and Disposition. Prilocaine- and Lidocaine-Induced Methemoglobinemia Is Caused by Human Carboxylesterase-, CYP2E1-, and CYP3A4-Mediated Metabolic Activation
In practice, clinically significant methemoglobinemia from prilocaine is uncommon at standard doses. It becomes a concern mainly when large doses are used, or in patients who already have conditions that impair their blood’s oxygen-carrying capacity, such as certain enzyme deficiencies or severe anemia. Newborns are also more vulnerable because their hemoglobin is more easily oxidized. When it does occur, the condition is usually treated promptly with methylene blue and resolves quickly. But this risk is the single biggest reason why prilocaine is not simply the default choice everywhere: clinicians have to weigh the wider seizure margin against the methemoglobin risk, especially in vulnerable populations.
Spinal Anesthesia and Nerve Irritation
One area where prilocaine clearly outperforms lidocaine is spinal anesthesia for short surgical procedures. Lidocaine was once a standard drug for spinal blocks, but it fell out of favor because of a side effect called transient neurologic symptoms: pain or discomfort in the buttocks and legs that appears within 24 hours of the spinal injection and can last several days. Multiple trials have shown that prilocaine causes this problem far less often.
In one randomized trial, 9 out of 30 patients who received lidocaine developed transient neurologic symptoms, compared with just 1 out of 30 who received prilocaine. The times to walking and bladder function were similar between the two groups, meaning prilocaine offered the same duration of action without the neurological downside.8PubMed. Transient neurologic symptoms after spinal anesthesia: a lower incidence with prilocaine and bupivacaine than with lidocaine A second trial found a 20 percent incidence of transient neurologic symptoms with intrathecal lidocaine and zero percent with prilocaine.9PubMed. The incidence of transient neurological symptoms after spinal anaesthesia with lidocaine compared to prilocaine Not every study has found such a dramatic gap; one trial using hyperbaric (heavy) formulations of both drugs at 5% concentration reported a low incidence in both groups, with 4 percent for lidocaine and 1 percent for prilocaine.10Anesthesiology. Incidence of Transient Neurologic Symptoms after Hyperbaric Subarachnoid Anesthesia with 5% Lidocaine and 5% Prilocaine Still, the overall weight of evidence has shifted practice: many anesthesiologists now prefer prilocaine (or other alternatives) over lidocaine for spinal blocks precisely because of this lower incidence of nerve irritation.
Intravenous Regional Anesthesia
Intravenous regional anesthesia, also known as Bier’s block, is a technique used for short procedures on the hand and forearm. A tourniquet isolates the limb, and the anesthetic is injected into a vein, where it diffuses into nearby tissues. Both prilocaine and lidocaine are routinely used for this purpose and are considered effective.11Journal of Anesthesia History. Intravenous Regional Anesthesia: A Historical Overview and Clinical Review
A comparative study found no significant difference in how quickly sensory and motor block set in. Lidocaine averaged about 5.5 minutes and prilocaine about 5.9 minutes to full block. Where they diverged was after the tourniquet was released: patients who received prilocaine recovered sensation more quickly, averaging about 5.4 minutes compared with 7.4 minutes for lidocaine. On the other hand, lidocaine provided better pain control during and after the surgery, with lower pain scores and fewer patients needing additional analgesia.12Al-Kindy College Medical Journal. A Comparative Study between Intravenous Lidocaine (0.5%) and Prilocaine (0.5%) in Intravenous Regional Anesthesia (Bier’s Block) The faster recovery with prilocaine can be an advantage for outpatient procedures where you want patients discharged quickly. The stronger analgesia with lidocaine can matter more for procedures that are expected to be painful. The wider systemic safety margin of prilocaine is also reassuring here, since accidental tourniquet failure is the main source of toxicity risk in this technique.
Topical Use and EMLA Cream
Prilocaine and lidocaine are not only competitors; they are also partners. EMLA cream, one of the most widely used topical anesthetics, is a eutectic mixture of both drugs. The combination lowers each drug’s melting point, allowing them to exist as an oil at room temperature that penetrates intact skin more effectively than either drug alone. This formulation is used before needle insertions, minor skin procedures, and wound care.
In burn patients, application of EMLA to second-degree burns before debridement produced effective pain relief: six out of eight patients reported no pain at all, and the remaining two reported only mild discomfort. Importantly, peak plasma concentrations of lidocaine and prilocaine after topical application to burns were far below levels associated with toxicity.13PubMed Central. EMLA anaesthetic cream for debridement of burns: a study of plasma concentrations of lidocaine and prilocaine and a review of the literature The main caution with EMLA is applying it to very large skin areas, especially in infants, because the prilocaine component can contribute to methemoglobin formation when absorbed systemically in large amounts.
Vasoconstrictor Pairings and Heart Considerations
Local anesthetics are frequently combined with vasoconstrictors to keep the drug concentrated at the injection site longer, improving the depth and duration of numbness. Lidocaine is most commonly paired with epinephrine (adrenaline), while prilocaine is sometimes paired with felypressin, a synthetic vasopressin analogue. These pairings produce different cardiovascular effects, which can matter for patients with heart disease or hypertension.
A crossover study in older adults with systemic diseases found distinct hemodynamic patterns. The prilocaine-felypressin combination raised both systolic and diastolic blood pressure at all measurement points. The lidocaine-epinephrine combination raised heart rate at all measurement points and actually lowered diastolic blood pressure at 5 and 10 minutes after injection.14PubMed Central. Cardiovascular Comparison of 2 Types of Local Anesthesia With Vasoconstrictor in Older Adults: A Crossover Study Neither profile is inherently safer for all cardiac patients. A patient whose main concern is tachycardia (rapid heartbeat) might do better with prilocaine-felypressin. A patient whose main concern is elevated blood pressure might fare better with lidocaine-epinephrine. This is one of the situations where the choice between the two drugs is genuinely individualized, and your dentist or anesthesiologist should be considering your specific cardiovascular history.
Prilocaine’s Unique Vascular Behavior
One subtle difference between the two drugs is how they interact with blood vessels. Most local anesthetics cause some degree of vasodilation at clinical concentrations, which is one reason vasoconstrictors are added. Prilocaine’s vascular effects turn out to involve a specific biological pathway. Research on human skin found that part of prilocaine’s vasoactive effect is mediated through the release of nitric oxide from the endothelium, the inner lining of blood vessels. Blocking nitric oxide production reduced the vascular response to prilocaine by about a third.15PubMed Central. Mechanisms contributing to the vaso-active effects of prilocaine in human skin Lidocaine does not share this specific mechanism to the same degree. In practical terms, this means prilocaine without a vasoconstrictor may produce slightly shorter-lasting numbness than lidocaine with epinephrine, because the drug is cleared from the injection site faster. When used plain (without any vasoconstrictor), prilocaine still provides adequate anesthesia for many dental and minor surgical procedures, which is useful for patients who cannot tolerate epinephrine.
How the Body Clears Each Drug
Lidocaine is metabolized almost entirely in the liver. For years, prilocaine was thought to be different: textbooks suggested it underwent significant breakdown in the lungs and kidneys as well, which would partly explain its lower blood levels and wider safety margin. However, experimental work using isolated perfused rat organs found that the lung’s ability to degrade prilocaine was relatively low, about 20 percent of the liver’s capacity per gram of tissue. The lungs appeared to temporarily hold onto prilocaine but then release it back into the circulation. The study concluded that prilocaine’s pattern of lung clearance was not substantially different from that of other amide anesthetics.16PubMed. Prilocaine elimination by isolated perfused rat lung and liver The liver remains the primary engine for clearing both drugs, which is worth knowing if you have liver disease: impaired liver function can prolong the action and increase the toxicity risk of either drug.
When Each Drug Is the Better Fit
There is no single answer to which anesthetic is better, but the decision tree is not especially complicated once you know the trade-offs. For routine dental work in a healthy adult, both drugs perform nearly identically in terms of onset, pain control, and patient comfort, so the choice often defaults to whichever your practitioner stocks and is experienced with. For spinal anesthesia in short procedures, prilocaine has a genuine advantage because it causes far fewer cases of transient neurologic symptoms. For procedures requiring large volumes of anesthetic or where accidental intravascular injection is a concern, prilocaine’s higher seizure threshold provides a meaningful safety buffer. For patients who cannot tolerate epinephrine, prilocaine plain is a practical alternative that still provides adequate numbness for many procedures.
Lidocaine keeps its edge in a few situations. Its longer track record means more formulations, more concentration options, and broader availability worldwide. In intravenous regional anesthesia, it provided better intraoperative analgesia in at least one direct comparison. And in any patient at elevated risk for methemoglobinemia, whether because of enzyme deficiencies, anemia, or extremes of age, lidocaine avoids the metabolic concern that makes prilocaine riskier.
Patients Who Need Extra Caution
A few groups of patients require particularly careful consideration when choosing between these two drugs. Infants under three months have immature enzyme systems and fetal hemoglobin that is more susceptible to oxidation, making prilocaine’s methemoglobin risk more significant. People with glucose-6-phosphate dehydrogenase deficiency or congenital methemoglobinemia are similarly vulnerable. On the other side, patients with a history of cardiac arrhythmias or who are taking beta-blockers may react differently to the epinephrine commonly bundled with lidocaine, making prilocaine-felypressin combinations worth considering.
Severe liver disease affects clearance of both drugs. Because neither drug is metabolized dramatically faster or slower than the other in the liver, the dose reduction considerations are broadly similar for both. Still, any patient with significant liver impairment should have their anesthetic doses adjusted conservatively regardless of which drug is chosen, and their clinician should be aware of the issue before the procedure begins.